Three new reports of results from two clinical trials of bimekizumab indicate that it is safe and efficacious for the long-term treatment of patients with ankylosing spondylitis or psoriatic arthritis.

中文翻译：

---

Bimekizumab 在长期试验中对 AS 和 PsA 安全有效

bimekizumab的两项临床试验的三份新结果报告表明，它对强直性脊柱炎或银屑病关节炎患者的长期治疗是安全有效的。